A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes

Heart

Volumn 89, Issue 5, 2003, Pages 512-516

  Foo, K ^b   Cooper, J ^c   Deaner, A ^b   Knight, C ^b   Suliman, A ^b   Ranjadayalan, K ^b   Timmis, Adam D ^a,b  

^a LONDON CHEST HOSPITAL   (United Kingdom)

^b BARTS HEALTH NHS TRUST   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; COHORT ANALYSIS; FEMALE; GLYCOLYSIS; HEART DEATH; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HOSPITAL DISCHARGE; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; METABOLIC REGULATION; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0242416651     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.89.5.512     Document Type: Article

References (28)

1. Oswald GA, Smith CCT, Betteridge DJ, et at. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. BMJ 1986;293:917-22.
2. Lynch M, Gammage MD, Lamb P, et al. Acute myocardial infarction in diabetic patients in the thrombolytic era. Diabet Med 1994;11:162-5.
3. Ravid M, Berkowicz M, Sohar E. Hyperglycemia during acute myocardial infarction: a six year follow-up study. JAMA 1975;233:807-9.
4. Bellodi G, Manicardi V, Malavasi V, et al. Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 1989;64:885-8.
5. Soler NG, Frank S. Value of glycosylated hemoglobin measurements after acute myocardial infarction. JAMA 1981;246:1690-3.
6. O'Sullivan JJ, Conroy RM, Robinson K, et al. In-hospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabet Care 1991;14:758-60.
7. Sewdarsen M, Vythilingum S, Jialal I, et al. Prognostic importance of admission plasma glucose in diabetic and non-diabetic patients with acute myocardial infarction. QJM 1989;71:461-6.
8. Gwilt DJ, Petri M, Lamb P, et al. Effect of intravenous insulin infusion on mortality among diabetic patients after myocardial infarction. Br Heart J 1984;51:626-30.
9. Stone PH, Muller JE, Hartvvell T, et al. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS study group. J Am Coll Cardiol 1989;14:49-57.
10. Granger CB, Califf RM, Young S, et al, and The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Outcome of patients with diabetes mellitus and acute myocardial infarction treated with thrombolytic agents. J Am Coll Cardiol 1993;21:920-5.
11. Woodfield SL, Lundergan CF, Reiner JS, et al. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol 1996;28:1661-9.
12. Mak KH, Moliterno DJ, Granger CB, et al. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries. J Am Coll Cardiol 1997;30:171-9.
13. Capes S, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355:773-8.
14. Lakhdar A, Stromberg P, McAlpine S. Prognostic importance of hyperglycaemia induced by stress after acute myocardial infarction. BMJ 1984;288:288.
15. Oswald GA, Smith CCT, Betteridge DJ, et al. Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocordial infarction. BMJ 1986;293:917-22.
16. Karlsberg RP, Cryer PE, Roberts R. Serial plasma catecholamine response early in the course of clinicol acute myocardial infarction: relation to infarct extent and mortality. Am Heart J 1981;102:24-9.
17. Malmberg K, Norhammer A, Wedel H, et al. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long term results from the DIGAMI study. Circulation 1999;99:2626-32.
18. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001;345:1359-67.
19. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994;343:155-8.
20. Mjos OD. Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. J Clin Invest 1971;50:1386-9.
21. Braunwald E. Unstable angina: a classification. Circulation 1989;80:410-4.
22. Malmberg K, Ryden L, Efendic S, et al, for the Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI) Study Group. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction: effects on mortality at 1 year. J Am Coll Cardiol 1995;26:57-65.
23. Savonitto S, Granger CB, Ardissino D, et al. The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes. J Am Coll Cardiol 2002;39:22-9.
24. Norris RM, Brandt PWT, Caughey DE, et al. A new coronary prognostic index. Lancet 1969;i:274-8.
25. Hillis LD, Forman S, Braunwald E, and the Thrombolysis in Myocardial Infarction (TIMI) Phase II Co-Investigators. Risk stratification before thrombolytic therapy in patients with acute myocardial infarction. J Am Coll Cardiol 1990;16:313-5.
26. Maggioni AP, Franzosi JG, Santoro E, et al, on behalf of the GISSI-2 and International Study Groups. Analysis of the risk of stroke in 20,891 patients with acute myocardial infarction following thrombolytic and antithrombotic treatment. N Engl J Med 1992;327:1-6.
27. Lee KL, Woodlief LH, Topol EJ, et al, for the GUSTO-1 Investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients. Circulation 1995;91:1659-68.
28. Stevenson R, Ranjadayalan K, Wilkinson P, et al. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. BMJ 1993;307:349-53.